R Mark Jones Selected Research

R Mark Jones Research Topics

5	Malaria 01/2018 - 01/2011
4	Human Influenza (Influenza) 01/2015 - 04/2012
3	Infections 01/2020 - 01/2018
3	Communicable Diseases (Infectious Diseases) 03/2013 - 04/2008
2	Anthrax 01/2016 - 01/2016
1	Rabies (Hydrophobia) 01/2022
1	Virus Diseases (Viral Diseases) 01/2020
1	Ebola Hemorrhagic Fever 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 12/2019
1	Fever (Fevers) 12/2019
1	Lymphopenia (Lymphocytopenia) 12/2019
1	Viremia 12/2019
1	Yellow Fever 01/2018
1	Neuroblastoma 08/2008
1	Botulism 04/2008
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 10/2006
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 10/2006
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2006

8	VaccinesIBA 12/2019 - 01/2011
4	AntigensIBA 01/2016 - 01/2011
3	Subunit VaccinesIBA 01/2018 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2015
2	AntibodiesIBA 01/2018 - 04/2008
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2015 - 04/2012
2	Hemagglutinins (Hemagglutinin)IBA 04/2012 - 04/2012
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2022
1	Polysaccharides (Glycans)IBA 01/2020
1	EpitopesIBA 01/2020
1	Combined Antibody TherapeuticsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Neutralizing AntibodiesIBA 01/2018
1	HydrogelsIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2016
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2013
1	incobotulinumtoxinA FDA Link 08/2008
1	Botulinum Toxins (Botulinum Toxin)IBA 04/2008
1	Immunoglobulin G (IgG)IBA 04/2008
1	PrionsIBA 10/2006

3	Therapeutics 01/2020 - 04/2008